Israel Englander’s CONMED CNMD Stock Holding History

Israel Englander’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,000	Closed	-$1.1M	–	6236
2023 Q4	$1.1M	Buy	+10,000	New	+$1.03M	﹤0.01%	4081
2022 Q3	–	Sell	-5,000	Closed	-$479K	–	7111
2022 Q2	$479K	Hold	5,000	–	–	﹤0.01%	4985
2022 Q1	$743K	Buy	+5,000	New	+$698K	﹤0.01%	4798
2021 Q4	–	Sell	-20,000	Closed	-$2.62M	–	6865
2021 Q3	$2.62M	Buy	20,000 +10,000	+100%	+$1.31M	﹤0.01%	3597
2021 Q2	$1.37M	Sell	10,000 -30,000	-75%	-$4.11M	﹤0.01%	4359
2021 Q1	$5.22M	Buy	40,000 +30,000	+300%	+$3.61M	﹤0.01%	2514
2020 Q4	$1.12M	Sell	10,000 -10,000	-50%	-$947K	﹤0.01%	3664
2020 Q3	$1.57K	Hold	20,000	–	–	﹤0.01%	2785
2020 Q2	$1.44M	Buy	20,000 +10,000	+100%	+$696K	﹤0.01%	2760
2020 Q1	$573K	Buy	+10,000	New	+$922K	﹤0.01%	2802

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Israel Englander's CNMD Position: Q2 2026 in Review

Israel Englander increased its CONMED (CNMD) stake by 51% in Q2 2026, buying an estimated $1.39M and bringing the position to 114,609 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #3274.

Israel Englander first reported a position in CNMD in Q2 2013 and has held it in 46 quarters since. The position peaked at $48.4M in Q4 2020. 245 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Israel Englander held 114,609 shares of CONMED worth $3.75M as of Q2 2026.
Israel Englander bought 38,700 CONMED shares in Q2 2026, an estimated $1.39M.
CONMED made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3274 holding.
Israel Englander first reported a position in CONMED in Q2 2013 and has held it in 46 quarters since.
Israel Englander's CONMED position peaked at $48.4M in Q4 2020.
245 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.